Evidence map›Paper›PMID 41826437›Full record

ArticleScientific reports2026

Perfluoroalkyl compound levels in breast milk of mothers in Riyadh, Kingdom of Saudi Arabia.

Eman Alharbi, Ezzeldeen Ghanem, Waleed Alhussaini, Alaa Aldahri, Magd Alsahly, Rabih O Al-Kaysi, Mohammed Almtiri, Bandar Alghanem, Saif Alsaif, Imadul Islam

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eman AlharbiPharmaceutical Analysis Center, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
Ezzeldeen GhanemPharmaceutical Analysis Center, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
Waleed AlhussainiPharmaceutical Analysis Center, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
Alaa AldahriPharmaceutical Analysis Center, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
Magd AlsahlyPharmaceutical Analysis Center, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
Rabih O Al-KaysiPharmaceutical Analysis Center, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
Mohammed AlmtiriPharmaceutical Analysis Center, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
Bandar AlghanemPharmaceutical Analysis Center, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
Saif AlsaifNeonatal Intensive Care Department, King Abdullah Specialized Children's Hospital, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
Imadul IslamPharmaceutical Analysis Center, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia. islamim@mngha.med.sa.

Funding

King Abdullah International Medical Research Center RC21R/075/03
6 · The paper itself

Abstract

Per- and Polyfluoroalkyl substances (PFAS) are persistent environmental contaminants widely used in consumer and industrial applications including stain- and water-repellent textiles, nonstick cookware, firefighting foams, and food packaging. Their persistence and bioaccumulation potential raise concerns about early-life exposure through breastfeeding. Despite increasing international attention, no biomonitoring data on PFAS in breast milk have been reported from Saudi Arabia. The study aim to quantify perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in breast milk from lactating women in Riyadh and estimate infant exposure via breastfeeding using standardized exposure assessment methods. Breast milk samples were collected from 25 mothers within 30 days postpartum. Samples were analyzed by LC-MS/MS following solid-phase extraction. Estimated daily intake (EDI) for PFOA and PFOS was calculated using the equation EDI = (CBM × VBM) / BW, assuming an average infant body weight of 2.5 kg and daily milk intake of 292.5 mL during early infancy. Quantifiable concentrations (> LLOQ = 25 ng/L) were detected in 4 of 25 participants. PFOA concentrations ranged from < LLOQ to 73.3 ng/L, and PFOS concentrations ranged from < LLOQ to 85.2 ng/L. Median concentrations for both compounds remained < LLOQ. Infant EDI values were below the U.S. EPA oral reference dose (20 ng/kg-bw/day) but exceeded EFSA benchmark values in 12% of samples for PFOA (EFSA = 0.857 ng/kg-bw/day) and 16% of samples for PFOS (EFSA = 1.857 ng/kg-bw/day). This study provides the first biomonitoring evidence of PFAS in breast milk in Saudi Arabia, demonstrating low but measurable exposure among lactating women. The findings underscore a need for expanded biomonitoring and assessment of potential exposure sources in the region.

Indexed as

Alkanesulfonic AcidsCaprylatesEnvironmental PollutantsFluorocarbonsMilk, HumanAdultBiological MonitoringBreast FeedingEnvironmental ExposureEnvironmental MonitoringFemaleHumansInfantLactationSaudi ArabiaTandem Mass SpectrometryAlkanesulfonic AcidsCaprylatesEnvironmental PollutantsFluorocarbonsperfluorooctane sulfonic acidperfluorooctanoic acidBiomonitoringBreastfeedingBreast milkChildEnvironmental pollutantsLC-MS/MSPFASPFOAPFOSRegulations

Identifiers

PMID41826437
PMCPMC13106757

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.